Linnea K Hur, MD | |
2200 Ofarrell St, San Francisco, CA 94115-3357 | |
(415) 833-2000 | |
Not Available |
Full Name | Linnea K Hur |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2200 Ofarrell St, San Francisco, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235201088 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | A90445 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Linnea K Hur, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Linnea K Hur, MD 2200 Ofarrell St, San Francisco, CA 94115-3357 Ph: (415) 833-2000 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,088,073, titled "Device for the Application of Acoustic Shock Waves."
Affecting an estimated one in eight people older than 75, aortic valve stenosis - a narrowing of the heart's main artery - makes the heart work harder to supply the body with blood, potentially limiting patient's activity levels an quality of life. Ultimately, aortic stenosis can lead to stroke, arrhythmia, heart failure and death.
Health Net Federal Services, LLC, the government operations division of Health Net, Inc. (NYSE:HNT), today announced its newly developed Extended Care Health Option (ECHO) kit for service members and their families in the TRICARE North Region, designed to provide user-friendly, educational information to enhance understanding of the ECHO program.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
In the future, diagnosing severe personality disorders, evaluating the childhood environment, assessing alcohol consumption and the analysis of the MAOA genotype may provide more accurate means for assessing risk among violent offenders, according to the Finnish research carried out jointly at the University of Helsinki and the Helsinki University Central Hospital Psychiatry Centre.
› Verified 3 days ago
Dr. Shannon Walker, Hospitalist Medicare: Medicare Enrolled Practice Location: 112 Parnassus Ave Apt 4, San Francisco, CA 94117 Phone: 571-271-8343 | |
Elizabeth A. Andrews, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000 | |
Deborah Chiarucci, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000 | |
Dr. Sneha Kemkar, Hospitalist Medicare: Medicare Enrolled Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 423-309-6170 | |
Dr. Fiona Henderson, Hospitalist Medicare: Medicare Enrolled Practice Location: 3555 Cesar Chavez Street, San Francisco, CA 94110 Phone: 415-647-8600 Fax: 415-641-6823 | |
Todd A. Levine, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000 | |
Jeannie Tran, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-476-7931 Fax: 415-476-4818 |